• Western blot analysis of HeLa cells using Flt3-L Polyclonal Antibody.. Secondary antibody was diluted at 1:20000

Anti-FLT3LG antibody (171-220 aa) (STJ96881)

SKU:
STJ96881

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Fms-related tyrosine kinase 3 ligand (171-220 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FLT3LG
Gene ID: 2323
Uniprot ID: FLT3L_HUMAN
Immunogen Region: 171-220 aa
Specificity: Flt3-L Polyclonal Antibody detects endogenous levels of Flt3-L protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the C-terminal region of human FLT3LG at the amino acid range 171-220
Protein Name Fms-Related Tyrosine Kinase 3 Ligand
Flt3 Ligand
Flt3l
Sl Cytokine
Database Links Reactome: R-HSA-109704
Reactome: R-HSA-1257604
Reactome: R-HSA-2219530
Reactome: R-HSA-5673001
Reactome: R-HSA-6811558
Reactome: R-HSA-9607240
Reactome: R-HSA-9645135
Reactome: R-HSA-9706369
Reactome: R-HSA-9706374
Reactome: R-HSA-9706377
Cellular Localisation Isoform 1: Cell Membrane
Single-Pass Type I Membrane Protein
Isoform 2: Secreted
Alternative Antibody Names Anti-Fms-Related Tyrosine Kinase 3 Ligand antibody
Anti-Flt3 Ligand antibody
Anti-Flt3l antibody
Anti-Sl Cytokine antibody
Anti-FLT3LG antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance